SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Technology Stocks : Dell Technologies Inc. -- Ignore unavailable to you. Want to Upgrade?


To: Mohan Marette who wrote (109258)3/12/1999 3:03:00 PM
From: William F. Wager, Jr.  Read Replies (1) | Respond to of 176387
 
Here's the deal on IBIS-------->

Ibis Tech Up 13%;Cites Boost From Last Week's IBM-Dell Deal

NEW YORK (Dow Jones)--Ibis Technology Corp. (IBIS) shares were up more than 13%
after hitting a 52-week high Friday on speculation that Dell Computer Corp. (DELL)
would buy technologies from International Business Machines Corp. (IBM) based on Ibis
products, the company said.

Ibis, of Danvers, Mass., has sold at least two of its high-current oxygen implanter
machines to IBM, which the computer giant uses to develop silicon-on-insulator, or SOI,
wafers for computer chips. As reported March 4, Dell and IBM signed a $16 billion
technology pact that is expected to include Dell's purchase of SOI technologies.

Ibis shares have risen more than 50% since the IBM-Dell announcement as investors
speculate that SOI technology will become standard in the chip-making industry, an
analyst said.

"The potential market for SOI is huge," said Westcountry Financial analyst James S.
Schmitt. SOI-based wafers may replace current silicon models in the next century, he
added.

When IBM announced last August it was developing SOI, it said it expected the
technology to help make computer chips that are up to 35% faster than current chips but
use much less power, which would extend the battery life of laptops, cell phones and
other products, as reported in The Wall Street Journal.

The SOI process is designed to protect the transistors on a chip with a blanket of
insulation, reducing harmful electrical effects that seap energy and hurt performance.

As reported last June, Ibis sold two of its Ibis 1000 implanters to IBM for $8 million and
reached an equipment licensing and development with IBM. IBM has the right to a
royalty-bearing, nonexclusive license to supplement Ibis equipment manufacturing
capacity.

Ibis shares earlier rose as high as 18, past the previous 52-week ceiling of 7 1/4 set July
30. They were recently up 2, or 13.3%, at 17, on volume of 523,900, compared with a
daily average of 85,600.

- Peter Loftus; 201-938-5099.